Evidence map›Paper›PMID 16632672›Full record

ReviewArchives of disease in childhood2006

Inflammatory bowel disease.

R M Beattie, N M Croft, J M Fell, N A Afzal, R B Heuschkel

Abstract readReview
In one paragraph

Review in Archives of disease in childhood, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

R M BeattiePaediatric Medical Unit, Southampton General Hospital, Southampton, UK. mark.beattie@suht.swest.nhs.uk
N M Croft
J M Fell
N A Afzal
R B Heuschkel

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Twenty five per cent of inflammatory bowel disease presents in childhood. Growth and nutrition are key issues in the management with the aim of treatment being to induce and then maintain disease remission with minimal side effects. Only 25% of Crohn's disease presents with the classic triad of abdominal pain, weight loss, and diarrhoea. Most children with ulcerative colitis have blood in the stool at presentation. Inflammatory markers are usually although not invariably raised at presentation (particularly in Crohn's disease). Full investigation includes upper gastrointestinal endoscopy and ileocolonoscopy. Treatment requires multidisciplinary input as part of a clinical network led by a paediatrician with special expertise in the management of the condition.

Indexed as

Inflammatory Bowel DiseasesAdolescentAdultAnti-Bacterial AgentsAnti-Inflammatory AgentsChildColitis, UlcerativeCrohn DiseaseDiagnosis, DifferentialGlucocorticoidsHumansImmunosuppressive AgentsAnti-Bacterial AgentsAnti-Inflammatory AgentsGlucocorticoidsImmunosuppressive Agents

Identifiers

PMID16632672
PMCPMC2082730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.